Geode Capital Management
MIRA icon

Geode Capital Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Geode Capital Management’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$311K Buy
290,890
+18,012
+7% +$22.6K ﹤0.01% 3762
2025
Q4 		$412K Buy
272,878
+136,438
+100% +$200K ﹤0.01% 3667
2025
Q3 		$186K Buy
136,440
+1,145
+0.8% +$1.66K ﹤0.01% 3945
2025
Q2 		$164K Sell
135,295
-123
-0.1% -$142 ﹤0.01% 3940
2025
Q1 		$133K Buy
135,418
+13,332
+11% +$15.2K ﹤0.01% 3951
2024
Q4 		$139K Buy
122,086
+6,172
+5% +$8.06K ﹤0.01% 4005
2024
Q3 		$151K Buy
+115,914
New +$185K ﹤0.01% 3989

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Geode Capital Management's MIRA Position: Q1 2026 in Review

Geode Capital Management increased its MIRA Pharmaceuticals (MIRA) stake by 6.6% in Q1 2026, buying an estimated $22.6K and bringing the position to 290,890 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #3762.

Geode Capital Management first reported a position in MIRA in Q3 2024 and has held it in 7 quarters since. The position peaked at $412K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Geode Capital Management held 290,890 shares of MIRA Pharmaceuticals worth $311K as of Q1 2026.
  • Geode Capital Management bought 18,012 MIRA Pharmaceuticals shares in Q1 2026, an estimated $22.6K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3762 holding.
  • Geode Capital Management first reported a position in MIRA Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Geode Capital Management's MIRA Pharmaceuticals position peaked at $412K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.